Cargando…

Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing

N-4 cytidine acetylation (ac4C) is an epitranscriptome modification catalyzed by N-acetyltransferase 10 (NAT10) and is essential for cellular mRNA stability, rRNA biosynthesis, cell proliferation, and epithelial-mesenchymal transition (EMT). Numerous studies have confirmed the inextricable link betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Dong, Huang, Kaige, Chen, Yang, Yang, Fei, Xia, Cunbing, Yang, Hongbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025374/ https://www.ncbi.nlm.nih.gov/pubmed/36949954 http://dx.doi.org/10.3389/fimmu.2023.1133166

Ejemplares similares

Identification of Molecular Targets and Underlying Mechanisms of Xiaoji Recipe against Pancreatic Cancer Based on Network Pharmacology
por: Xia, Cunbing, et al.
Publicado: (2022)

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
por: Zhang, Huiru, et al.
Publicado: (2022)

ITGB5 Plays a Key Role in Escherichia coli F4ac-Induced Diarrhea in Piglets
por: Wang, Wenwen, et al.
Publicado: (2019)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy
por: Pinte, Laetitia, et al.
Publicado: (2021)

Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma
por: Yuan, Hao, et al.
Publicado: (2021)

Identification of prognostic immune-related lncRNAs in pancreatic cancer
por: Ma, Yan, et al.
Publicado: (2022)

IL-19 Up-Regulates Mucin 5AC Production in Patients With Chronic Rhinosinusitis via STAT3 Pathway
por: Lai, Xiaoping, et al.
Publicado: (2019)

An immune-related gene prognostic risk index for pancreatic adenocarcinoma
por: Su, Yang, et al.
Publicado: (2022)

Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma
por: Ma, Junrui, et al.
Publicado: (2023)

PP2Cδ Controls the Differentiation and Function of Dendritic Cells Through Regulating the NSD2/mTORC2/ACLY Pathway
por: Lv, Nianyin, et al.
Publicado: (2022)

The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
por: González-Navajas, Jose M., et al.
Publicado: (2021)

Targeting C-Type Lectin Receptors for Cancer Immunity
por: Yan, Huimin, et al.
Publicado: (2015)

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis
por: Yang, Bing, et al.
Publicado: (2021)

C-Type Lectin Receptors in Antiviral Immunity and Viral Escape
por: Bermejo-Jambrina, Marta, et al.
Publicado: (2018)

Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity
por: Tang, Juan, et al.
Publicado: (2018)

The diverse roles of C-type lectin-like receptors in immunity
por: Scur, Michal, et al.
Publicado: (2023)

Regulation of Type 2 Immunity in Myocardial Infarction
por: Xu, Jun-Yan, et al.
Publicado: (2019)

Immune-based combination therapy for esophageal cancer
por: Wang, Huiling, et al.
Publicado: (2022)

Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
por: Li, Tianhang, et al.
Publicado: (2022)

miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
por: Xi, Qing, et al.
Publicado: (2020)

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
por: Yang, Huijie, et al.
Publicado: (2022)

Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation
por: del Fresno, Carlos, et al.
Publicado: (2018)

Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity
por: Patin, Emmanuel C., et al.
Publicado: (2017)

Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment
por: Sang, Xiaoqing, et al.
Publicado: (2021)

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
por: Guo, Yongdong, et al.
Publicado: (2021)

Inulin-Type Fructans Modulates Pancreatic–Gut Innate Immune Responses and Gut Barrier Integrity during Experimental Acute Pancreatitis in a Chain Length-Dependent Manner
por: He, Yue, et al.
Publicado: (2017)

A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation
por: Chang, Ting-Ting, et al.
Publicado: (2021)

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma
por: Jia, Jianlong, et al.
Publicado: (2022)

C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity
por: Drouin, Marion, et al.
Publicado: (2020)

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
por: Maes, Ken, et al.
Publicado: (2021)

Corrigendum: Inulin-Type Fructans Modulates Pancreatic-Gut Innate Immune Responses and Gut Barrier Integrity during Experimental Acute Pancreatitis in a Chain Length-Dependent Manner
por: He, Yue, et al.
Publicado: (2018)

Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
por: Yang, Shih-Hung, et al.
Publicado: (2022)

Comprehensive analysis of m(6)A/m(5)C/m(1)A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in glioma
por: Zhao, Kai, et al.
Publicado: (2022)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
por: Xiao, Mingjia, et al.
Publicado: (2022)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Innate immunity in pancreatic cancer: Lineage tracing and function
por: Ye, Longyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3jqp2672nkmmfq51pik4ors9ip